Literature DB >> 4694545

Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases.

H M Foy, H Ochs, S D Davis, G E Kenny, R R Luce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4694545     DOI： 10.1093/infdis/127.4.388

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  31 in total

Review 1.  Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses.

Authors:  P Andersen
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

2.  First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.

Authors:  Otavio Cabral-Marques; Stefanie Klaver; Lena F Schimke; Évelyn H Ascendino; Taj Ali Khan; Paulo Vítor Soeiro Pereira; Angela Falcai; Alexander Vargas-Hernández; Leopoldo Santos-Argumedo; Liliana Bezrodnik; Ileana Moreira; Gisela Seminario; Daniela Di Giovanni; Andrea Gómez Raccio; Oscar Porras; Cristina Worm Weber; Janaíra Fernandes Ferreira; Fabiola Scancetti Tavares; Elisa de Carvalho; Claudia França Cavalcante Valente; Gisele Kuntze; Miguel Galicchio; Alejandra King; Nelson Augusto Rosário-Filho; Milena Baptistella Grota; Maria Marluce dos Santos Vilela; Regina Sumiko Watanabe Di Gesu; Simone Lima; Leiva de Souza Moura; Eduardo Talesnik; Eli Mansour; Pérsio Roxo-Junior; Juan Carlos Aldave; Ekaterine Goudouris; Fernanda Pinto-Mariz; Laura Berrón-Ruiz; Tamara Staines-Boone; Wilmer O Córdova Calderón; María del Carmen Zarate-Hernández; Anete S Grumach; Ricardo Sorensen; Anne Durandy; Troy R Torgerson; Beatriz Tavares Costa Carvalho; Francisco Espinosa-Rosales; Hans D Ochs; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2014-01-09       Impact factor: 8.317

3.  Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation.

Authors:  G Biberfeld; P Biberfeld; G Sterner
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

4.  Severe disseminated lung disease and bronchiectasis probably due to Mycoplasma pneumoniae.

Authors:  F Halal; P Brochu; G Delage; A Lamarre; G Rivard
Journal:  Can Med Assoc J       Date:  1977-11-05       Impact factor: 8.262

5.  Severe mycoplasma pneumonia.

Authors:  S Holt; W F Ryan; E J Epstein
Journal:  Thorax       Date:  1977-02       Impact factor: 9.139

6.  Mycoplasmal (ureaplasma) septic arthritis in hypogammaglobulinaemia.

Authors:  A D Webster; D Taylor-Robinson; P M Furr; G L Asherson
Journal:  Br Med J       Date:  1978-02-25

7.  Life-threatening Mycoplasma pneumoniae infection.

Authors:  R McGonigle; J K Wagstaff
Journal:  Postgrad Med J       Date:  1980-09       Impact factor: 2.401

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Central nervous system complications of Mycoplasma pneumoniae.

Authors:  G Decaux; M Szyper; M Ectors; A Cornil; L Franken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-10       Impact factor: 10.154

Review 10.  Mycoplasma pneumoniae infections of adults and children.

Authors:  J D Cherry; R C Welliver
Journal:  West J Med       Date:  1976-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.